Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,334 warrant series at 1,058 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Warrants (July 2024 concurrent private placement) | $0.9521 | $13.3M | S-1, Oct 27, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series B Warrants (July 2024 concurrent private placement) | $0.9521 | $13.3M | S-1, Oct 27, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series C Warrants (October 2024 Registered Direct Offering) | $0.9521 | $13.3M | 424B3, Nov 5, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series E Warrants (September 2025 public offering) | $0.9521 | $13.3M | 424B4, Sep 16, 2025Dilution tabAs of Nov 11, 2026 | ||||||||
| Series F Warrants (September 2025 public offering) | $0.9521 | $13.3M | 424B4, Sep 16, 2025Dilution tabAs of Nov 11, 2026 | ||||||||
| Representative's Warrants (IPO, Aegis Capital Corp., issued December 2024) | $0.7700 | $13.3M | 6-K EX-99.1, Aug 27, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series A Warrants (September 2025 Public Offering) | $0.7700 | $13.3M | 6-K EX-99.1, Aug 27, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B Warrants (September 2025 Public Offering) | $0.7700 | $13.3M | 6-K EX-99.1, Aug 27, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| April 2023 Peak Bio Warrants (equity-classified, amended) | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2023 Peak Bio Warrants (liability-classified) | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2025 Series A Investor Warrants (extended to 4/25/2030) | $5.70 | $13.3M | 10-K, Mar 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2025 Series B Investor Warrants | $5.70 | $13.3M | 10-K, Mar 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2021 Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2021 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2025 Investor Prefunded Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2025 Note Exchange Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2025 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| December 2025 Series G Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2022 Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2022 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2024 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2025 Series A Investor Warrants (extended to 3/6/2030) | $5.70 | $13.3M | 10-K, Mar 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2025 Series B Investor Warrants | $5.70 | $13.3M | 10-K, Mar 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2024 Investor Warrants (Series C) | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2024 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2026 Investor Prefunded Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2026 Series H Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2026 Series H Warrants — Abeyance Shares | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2026 Series I Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2026 Series J Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| November 2022 Peak Bio Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| November 2024 Investor Warrants (Series D) | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2023 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2025 Placement Agent Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2025 Series E Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2025 Series F Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| September 2022 Series B Investor Warrants | $5.70 | $13.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Underwriter's Warrant (Alexander Capital, L.P.) — IPO representative's warrant | $0.3913 | $13.2M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Private Warrants (Plutonian private placement warrants assumed in the Business Combination) | $2.78 | $13.2M | 20-F, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| Public Warrants (Plutonian IPO warrants assumed in the Business Combination; Nasdaq: DSYWW) | $2.78 | $13.2M | 20-F, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| July 2026 Registered Direct Pre-Funded Warrants | $1.15 | $13.0M | 424B5, Jul 22, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Lock-up consideration pre-funded warrants (February 2026) | $1.15 | $13.0M | 10-K, Mar 19, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Pre-funded warrants issued on Series D/D-1/D-2/D-3 Preferred mandatory conversion (September 2025) | $1.15 | $13.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| September 2025 Pre-Funded Warrants | $1.15 | $13.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Warrants (other than pre-funded) — aggregate stated in July 2026 prospectus supplement | $1.15 | $13.0M | 424B5, Jul 22, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Underwriter's Warrants (Network1 Financial Securities, IPO March 2025) | $0.3694 | $12.9M | 6-K, Mar 11, 2025Dilution tabAs of Oct 24, 2026 | ||||||||
| April 2025 Warrant (SFO IDF LLC) – 500,000 shares at $0.49 | $0.5000 | $12.9M | 4, Apr 23, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| April 2026 Warrant (SFO IDF LLC) – 6,000,000 shares at $0.50 | $0.5000 | $12.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| December 2024 Exchange Warrant (originally Nanosha; now SFO IDF LLC) – 2,258,877 shares at $0.49 | $0.5000 | $12.9M | 4, Apr 23, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| December 2025 Warrant (SFO IDF LLC) – 1,000,000 shares at $0.50 | $0.5000 | $12.9M | 4, Apr 23, 2026Dilution tabAs of Nov 16, 2026 |
BNGOBionano Genomics, Inc.$0.9521Last price
Series A Warrants (July 2024 concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
BNGOBionano Genomics, Inc.$0.9521Last price
Series B Warrants (July 2024 concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
BNGOBionano Genomics, Inc.$0.9521Last price
Series C Warrants (October 2024 Registered Direct Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
BNGOBionano Genomics, Inc.$0.9521Last price
Series E Warrants (September 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
BNGOBionano Genomics, Inc.$0.9521Last price
Series F Warrants (September 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
YAASYouxin Technology Ltd Class A Ordinary shares$0.7700Last price
Representative's Warrants (IPO, Aegis Capital Corp., issued December 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
YAASYouxin Technology Ltd Class A Ordinary shares$0.7700Last price
Series A Warrants (September 2025 Public Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
YAASYouxin Technology Ltd Class A Ordinary shares$0.7700Last price
Series B Warrants (September 2025 Public Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
April 2023 Peak Bio Warrants (equity-classified, amended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
April 2023 Peak Bio Warrants (liability-classified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
April 2025 Series A Investor Warrants (extended to 4/25/2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
April 2025 Series B Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2021 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2021 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2025 Investor Prefunded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2025 Note Exchange Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
December 2025 Series G Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
March 2022 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
March 2022 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
March 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
March 2025 Series A Investor Warrants (extended to 3/6/2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
March 2025 Series B Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2024 Investor Warrants (Series C)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2026 Investor Prefunded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2026 Series H Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2026 Series H Warrants — Abeyance Shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2026 Series I Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
May 2026 Series J Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
November 2022 Peak Bio Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
November 2024 Investor Warrants (Series D)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
October 2023 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
October 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
October 2025 Series E Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
October 2025 Series F Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
AKTXAkari Therapeutics, Plc$5.70Last price
September 2022 Series B Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.3M
TGHLThe GrowHub Limited Class A Ordinary Shares$0.3913Last price
Underwriter's Warrant (Alexander Capital, L.P.) — IPO representative's warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.2M
DSYBig Tree Cloud Holdings Limited Class A Ordinary Shares$2.78Last price
Private Warrants (Plutonian private placement warrants assumed in the Business Combination)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.2M
DSYBig Tree Cloud Holdings Limited Class A Ordinary Shares$2.78Last price
Public Warrants (Plutonian IPO warrants assumed in the Business Combination; Nasdaq: DSYWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.2M
DRIODarioHealth Corp.$1.15Last price
July 2026 Registered Direct Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.0M
DRIODarioHealth Corp.$1.15Last price
Lock-up consideration pre-funded warrants (February 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.0M
DRIODarioHealth Corp.$1.15Last price
Pre-funded warrants issued on Series D/D-1/D-2/D-3 Preferred mandatory conversion (September 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.0M
DRIODarioHealth Corp.$1.15Last price
September 2025 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.0M
DRIODarioHealth Corp.$1.15Last price
Warrants (other than pre-funded) — aggregate stated in July 2026 prospectus supplement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.0M
MCRPMicropolis AI Robotics$0.3694Last price
Underwriter's Warrants (Network1 Financial Securities, IPO March 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$12.9M
GEDCTerraVolt Holdings, Inc.$0.5000Last price
April 2025 Warrant (SFO IDF LLC) – 500,000 shares at $0.49
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$12.9M
GEDCTerraVolt Holdings, Inc.$0.5000Last price
April 2026 Warrant (SFO IDF LLC) – 6,000,000 shares at $0.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$12.9M
GEDCTerraVolt Holdings, Inc.$0.5000Last price
December 2024 Exchange Warrant (originally Nanosha; now SFO IDF LLC) – 2,258,877 shares at $0.49
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$12.9M
GEDCTerraVolt Holdings, Inc.$0.5000Last price
December 2025 Warrant (SFO IDF LLC) – 1,000,000 shares at $0.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$12.9M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 18, 2026.
Read from 2,083 dilution snapshots. 4,882 of 5,334 series state an exercise price and 3,363 an expiry date. 289 record when exercise begins; that count grows as companies are re-extracted. 628 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.